Growth and growth hormone in children born small for gestational age

Area of Science:

• Pediatrics
• Endocrinology
• Growth and Development

Background:

• Lack of uniform definitions for
• small for gestational age
• (SGA) and
• catch-up growth
• hinders evaluation of children born small.

Purpose of the Study:

• To emphasize the need for standardized terminology in evaluating SGA children.
• To highlight the potential of growth hormone (GH) therapy for improving height in SGA children.
• To outline essential components for successful GH therapy: precise definitions, candidate identification, and personalized treatment.

Main Methods:

• Literature review and expert consensus on terminology and therapeutic approaches.
• Analysis of data supporting growth hormone therapy efficacy in SGA populations.
• Discussion of challenges and considerations for implementing standardized protocols.

Main Results:

• Current lack of standardized definitions for SGA and catch-up growth is a significant barrier.
• Growth hormone therapy is a viable option for increasing height in children born SGA.
• Successful treatment necessitates defined terminology, systematic surveillance, and individualized care plans.

Conclusions:

• Standardization of terminology is paramount for accurate assessment and effective treatment of SGA children.
• Growth hormone therapy offers a promising avenue for improving growth outcomes in this population.
• Addressing implementation challenges is key to optimizing therapeutic success and patient care.